RSLS
$0.48
Reshape Lifesciences
$.03
7.67%
RSLS
Earnings Whisper ®
N/A
Consensus:  $0.00
Revenue:  N/A
Monday
Aug 15
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch
Latest EPS

What do you expect when RSLS reports earnings?
Beat
Meet
Miss

Where is RSLS's stock price going from here?
Up
Flat
Down
Stock chart of RSLS
Analysts
Summary of analysts' recommendations for RSLS
Score
Grade
Pivots
Resistance
$1.04
$0.92
$0.69

$0.56

Support
$0.33
$0.21
($0.03)
Tweet
Growth
Description
ReShape Lifesciences Inc. is a developer of invasive medical devices to treat obesity and metabolic diseases. The company's portfolio includes vBloc System(R), ReShape(R) and Gastric Vest System (TM). ReShape Lifesciences Inc., formerly known as EnteroMedics Inc., is based in CA, United States.